Broos Wouter A M, van der Zant Friso M, Knol Remco J J, Wondergem Maurits
Department of Nuclear Medicine, Northwest Clinics, Alkmaar, The Netherlands.
Nucl Med Commun. 2019 Feb;40(2):96-105. doi: 10.1097/MNM.0000000000000952.
One of the most promising imaging techniques in primary hyperparathyroidism is PET/CT with choline-based tracers. To investigate the current evidence of these tracers in localizing parathyroid adenoma, a systematic review was performed. A comprehensive literature search was carried out and eligible studies were analyzed. Data were extracted, the level of evidence was scored, and performance data were pooled to calculate the weighted detection rate. Eleven articles were included in this study. The pooled detection rate was 97 and 94% on per patient-based and per lesion-based analysis, respectively. There was considerable heterogeneity between studies and the level of evidence was determined to be 3a-, following Oxford criteria. Choline PET/CT has shown favorable results in detection of hyperfunctioning parathyroid tissue and may replace conventional technetium-99m-sestamibi scintigraphy in preoperative planning of parathyroid surgery. However, the quality of current evidence is moderate, and additional high-quality studies are needed to confirm these numbers.
正电子发射断层显像/计算机断层扫描(PET/CT)联合胆碱类示踪剂是原发性甲状旁腺功能亢进症中最具前景的成像技术之一。为研究这些示踪剂在定位甲状旁腺腺瘤方面的现有证据,我们进行了一项系统评价。开展了全面的文献检索并分析符合条件的研究。提取数据、对证据水平进行评分,并汇总性能数据以计算加权检测率。本研究纳入了11篇文章。基于患者和基于病灶的分析中,汇总检测率分别为97%和94%。各研究之间存在相当大的异质性,根据牛津标准,证据水平确定为3a级。胆碱PET/CT在检测功能亢进的甲状旁腺组织方面已显示出良好结果,并且在甲状旁腺手术的术前规划中可能会取代传统的锝-99m-甲氧基异丁基异腈闪烁显像。然而,当前证据的质量中等,需要更多高质量研究来证实这些数据。